THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN.
Q1 Fiscal 2024 Highlights Gross profit of $2.1 million, an 18.8% increase over Q4 2023 Revenue of $5.9 million, a 3.0% decline over Q4 2023 Reduced operating.
Q1 Fiscal 2024 Highlights
Gross profit of $2.1 million, an 18.8% increase over Q4 2023Revenue of $5.9 million, a 3.0% decline over Q4 2023Reduced operating expenditures of 19.9% over Q4 2023Cash.
The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health conditions, this sector has attracted growing attention and investment.
VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ - Numinus Wellness Inc. , a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies,.